37.00
price up icon6.75%   2.34
after-market Handel nachbörslich: 37.00
loading
Schlusskurs vom Vortag:
$34.66
Offen:
$37.5
24-Stunden-Volumen:
1.80M
Relative Volume:
2.02
Marktkapitalisierung:
$4.11B
Einnahmen:
$418.33M
Nettoeinkommen (Verlust:
$-252.07M
KGV:
-15.42
EPS:
-2.4
Netto-Cashflow:
$-238.84M
1W Leistung:
+5.14%
1M Leistung:
+7.09%
6M Leistung:
+38.94%
1J Leistung:
+87.82%
1-Tages-Spanne:
Value
$36.40
$38.77
1-Wochen-Bereich:
Value
$33.55
$38.77
52-Wochen-Spanne:
Value
$16.01
$44.34

Zai Lab Limited Adr Stock (ZLAB) Company Profile

Name
Firmenname
Zai Lab Limited Adr
Name
Telefon
862161632588
Name
Adresse
4560 JINKE ROAD, SHANGHAI
Name
Mitarbeiter
1,844
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
ZLAB's Discussions on Twitter

Vergleichen Sie ZLAB mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ZLAB
Zai Lab Limited Adr
37.00 3.88B 418.33M -252.07M -238.84M -2.40
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Zai Lab Limited Adr Stock (ZLAB) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-03-07 Eingeleitet Scotiabank Sector Outperform
2025-03-03 Herabstufung BofA Securities Buy → Neutral
2023-12-14 Eingeleitet Morgan Stanley Overweight
2023-08-10 Eingeleitet Cantor Fitzgerald Overweight
2022-01-21 Eingeleitet Macquarie Outperform
2021-10-12 Eingeleitet Bernstein Mkt Perform
2020-04-28 Eingeleitet Goldman Buy
2020-04-15 Eingeleitet Guggenheim Buy
2019-07-12 Eingeleitet BofA/Merrill Buy
2019-07-05 Eingeleitet Macquarie Outperform
2019-01-29 Eingeleitet Credit Suisse Outperform
2018-11-21 Eingeleitet Jefferies Buy
2018-06-21 Fortgesetzt Leerink Partners Outperform
2018-02-14 Hochstufung JP Morgan Neutral → Overweight
2017-10-16 Eingeleitet JP Morgan Neutral
2017-10-16 Eingeleitet Leerink Partners Outperform
Alle ansehen

Zai Lab Limited Adr Aktie (ZLAB) Neueste Nachrichten

pulisher
Jul 16, 2025

Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities - Benzinga

Jul 16, 2025
pulisher
Jul 16, 2025

Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities16.07.25News - Ariva

Jul 16, 2025
pulisher
Jul 15, 2025

M&T Bank Corp Reduces Stock Holdings in Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) - Defense World

Jul 15, 2025
pulisher
Jul 10, 2025

Zai Lab to Announce Second Quarter 2025 Financial Results and Recent Corporate Updates on August 7, 2025 - Business Wire

Jul 10, 2025
pulisher
Jul 03, 2025

Leerink Partnrs Issues Positive Outlook for Zai Lab Earnings - Defense World

Jul 03, 2025
pulisher
Jun 30, 2025

Zai Lab Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor Receptor 2b (FGFR2b) Positive First-Line Gastric Cancer - Business Wire

Jun 30, 2025
pulisher
Jun 26, 2025

Cantor Fitzgerald Expects Reduced Earnings for Zai Lab - Defense World

Jun 26, 2025
pulisher
Jun 20, 2025

Zai Lab (ZLAB) Delivers Positive ZL-1503 Trial Results in Treatment of Atopic Dermatitis - Yahoo Finance

Jun 20, 2025
pulisher
Jun 18, 2025

Metric Deep Dive: Understanding Winnebago Industries, Inc (WGO) Through its Ratios - DWinneX

Jun 18, 2025
pulisher
Jun 18, 2025

Zai Lab Limited ADR (ZLAB) Stock: A Year of Stock Market Dynamics - investchronicle.com

Jun 18, 2025
pulisher
Jun 18, 2025

10 Biotech Stocks Screaming a Buy - Insider Monkey

Jun 18, 2025
pulisher
Jun 16, 2025

Revenues Not Telling The Story For Zai Lab Limited (NASDAQ:ZLAB) After Shares Rise 33% - simplywall.st

Jun 16, 2025
pulisher
Jun 13, 2025

Zai Lab Presents New Preclinical Data for ZL-1503, an IL-13/IL-31R Bispecific Antibody for the Treatment of Atopic Dermatitis, at EAACI Congress 2025 - Business Wire

Jun 13, 2025
pulisher
Jun 12, 2025

Zai Lab Limited ADR (ZLAB) Stock: Uncovering 52-Week Market Trends - investchronicle.com

Jun 12, 2025
pulisher
Jun 12, 2025

CarParts.com Inc (PRTS) Stock: Navigating a Year of Stock Volatility - investchronicle.com

Jun 12, 2025
pulisher
Jun 11, 2025

Yatsen And Zai Lab Shine As Asian ADRs Climb In The US - Finimize

Jun 11, 2025
pulisher
Jun 09, 2025

Zai Lab Limited (NASDAQ:ZLAB) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Jun 09, 2025
pulisher
Jun 08, 2025

Two Sigma Investments LP Trims Stock Holdings in Zai Lab Limited (NASDAQ:ZLAB) - Defense World

Jun 08, 2025
pulisher
Jun 05, 2025

Two Sigma Advisers LP Boosts Stock Position in Zai Lab Limited (NASDAQ:ZLAB) - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Bank of America Corp DE Has $1.63 Million Stock Holdings in Zai Lab Limited (NASDAQ:ZLAB) - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Zai Lab Limited (ZLAB) & NovoCure Limited (NVCR)’s TTFields Therapy Succeeds in Phase 3 Trial - MSN

Jun 05, 2025
pulisher
Jun 04, 2025

Insider Sell: Yajing Chen Sells 9,618 Shares of Zai Lab Ltd (ZLA - GuruFocus

Jun 04, 2025
pulisher
Jun 02, 2025

Zai Lab Presents Positive Phase 1 Data for ZL-1310, a DLL3-Targeted ADC, Demonstrating Robust Anti-Tumor Activity and Safety in Patients with Extensive-Stage Small Cell Lung Cancer at 2025 ASCO Annual Meeting - Business Wire

Jun 02, 2025
pulisher
Jun 01, 2025

Zai Lab Limited (NASDAQ:ZLAB) Sees Large Drop in Short Interest - Defense World

Jun 01, 2025
pulisher
May 31, 2025

Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting - Yahoo Finance

May 31, 2025
pulisher
May 31, 2025

What Analysts Were Expecting After Zai Lab Limited ADR (NASDAQ: ZLAB) fell -3.74% - Stocksregister

May 31, 2025
pulisher
May 30, 2025

Zai Lab Announces Participation in Investor Conferences in June 2025 - BioSpace

May 30, 2025
pulisher
May 30, 2025

Zai Lab Lines Up Triple Conference Presence: Jefferies, Goldman Sachs, and Scotiabank Healthcare Events - Stock Titan

May 30, 2025
pulisher
May 30, 2025

Zai Lab Announces Participation in Investor Conferences in June 2025 | User | poteaudailynews.com - FinancialContent

May 30, 2025
pulisher
May 28, 2025

Northern Trust Corp Increases Holdings in Zai Lab Limited (NASDAQ:ZLAB) - Defense World

May 28, 2025
pulisher
May 27, 2025

Quantinno Capital Management LP Reduces Position in Zai Lab Limited (NASDAQ:ZLAB) - Defense World

May 27, 2025
pulisher
May 25, 2025

BNP Paribas Financial Markets Purchases 18,472 Shares of Zai Lab Limited (NASDAQ:ZLAB) - Defense World

May 25, 2025
pulisher
May 19, 2025

Zai Lab Receives U.S. FDA Fast Track Designation for ZL-1310, a DLL3-Targeted Antibody-Drug Conjugate, for Treatment of Extensive-Stage Small Cell Lung Cancer - BioSpace

May 19, 2025
pulisher
May 15, 2025

Barclays PLC Boosts Stake in Zai Lab Limited (NASDAQ:ZLAB) - Defense World

May 15, 2025
pulisher
May 15, 2025

Cantor Fitzgerald Expects Increased Earnings for Zai Lab - Defense World

May 15, 2025
pulisher
May 13, 2025

Zai Lab Limited (NASDAQ:ZLAB) Q1 2025 Earnings Call Transcript - Insider Monkey

May 13, 2025
pulisher
May 11, 2025

Zai Lab Limited (ZLAB) Reports Q1 Earnings: What Key Metrics Have to Say - MSN

May 11, 2025
pulisher
May 09, 2025

Decoding Zai Lab Ltd (ZLAB): A Strategic SWOT Insight - GuruFocus

May 09, 2025
pulisher
May 08, 2025

Zai Lab Announces First Quarter 2025 Financial Results and Recent Corporate Updates - Yahoo Finance

May 08, 2025
pulisher
May 07, 2025

Trading Day Triumph: Zai Lab Limited ADR (ZLAB) Ends at 29.38, a -5.07 Surge/Plunge - DWinneX

May 07, 2025
pulisher
May 05, 2025

Raymond James Financial Inc. Makes New $1.03 Million Investment in Zai Lab Limited (NASDAQ:ZLAB) - Defense World

May 05, 2025
pulisher
May 02, 2025

Zai Lab Limited (NASDAQ:ZLAB) Shares Bought by Invesco Ltd. - Defense World

May 02, 2025
pulisher
May 02, 2025

Envestnet Asset Management Inc. Buys New Shares in Zai Lab Limited (NASDAQ:ZLAB) - Defense World

May 02, 2025
pulisher
May 01, 2025

Geode Capital Management LLC Boosts Position in Zai Lab Limited (NASDAQ:ZLAB) - Defense World

May 01, 2025
pulisher
Apr 30, 2025

Post-Trade Analysis: VICI Properties Inc (VICI) Climbs 0.06, Closing at 32.26 - DWinneX

Apr 30, 2025
pulisher
Apr 30, 2025

Market Insights: Canadian Solar Inc (CSIQ)’s Notable Drop of -1.73, Closing at 9.65 - DWinneX

Apr 30, 2025
pulisher
Apr 30, 2025

Daily Market Movement: Faraday Future Intelligent Electric Inc (FFAI) Sees a -0.76 Decrease, Closing at 1.30 - DWinneX

Apr 30, 2025
pulisher
Apr 30, 2025

In the Green: Zai Lab Limited ADR (ZLAB) Closes at 31.84, Up/Down -1.82 from Previous Day - DWinneX

Apr 30, 2025
pulisher
Apr 30, 2025

Closing Bell Recap: C.H. Robinson Worldwide, Inc (CHRW) Ends at 88.33, Reflecting a -0.84 Downturn - DWinneX

Apr 30, 2025
pulisher
Apr 30, 2025

Zai Lab Limited ADR (ZLAB) is looking forward to a strong quarter - Sete News

Apr 30, 2025
pulisher
Apr 30, 2025

Wells Fargo & Company MN Grows Stake in Zai Lab Limited (NASDAQ:ZLAB) - Defense World

Apr 30, 2025

Finanzdaten der Zai Lab Limited Adr-Aktie (ZLAB)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):